OasisLMS

ACMG Education Webinar Series: Translating Genes into Health® On-Demand

Date of Release: July 1, 2025

Expiration Date: June 30, 2027

Credits offered: CME AMA PRA Category 1 Credit^TM 

Estimate time of completion: 8.5 hours

Specialized events developed by ACMG Committees.

Course Description

The ACMG Webinar Series: Translating Genes into Health® is a collaborative educational initiative designed to showcase the expertise and contributions of ACMG committees while addressing emerging and impactful topics in medical genetics and genomics. This series provides a platform for thought leaders, researchers, and clinicians to engage in meaningful discussions on advancements in genetic testing, clinical applications, ethical considerations, and health equity.

Through interactive, expert-led sessions, participants will gain valuable insights into cutting-edge research, translational genomics, and best practices in patient care. Each session is developed in collaboration with ACMG committees, reflecting their ongoing efforts to shape the future of clinical genetics through education, policy, and innovation.

2025 Webinar Series Topics:

• Back to Basics: The Physical Exam is the Cornerstone of Precision Medicine
• Novel Splice-Driven Mechanisms of Human Genetic Diseases Unveiled by Long-Read RNA-Sequencing
• How a Biochemical Genetics Laboratory Confirmation Testing Interfaces with Positive Newborn Screening Tests: Case Focus on Homocystinuria and Duchenne Muscular Dystrophy 

• Genomics-Informed Government Policy: Starting the Conversation with Policymakers

• A Nutrition Focused Approach to Team-Based Care in Metabolic Genetics: Integrating Clinical, Laboratory, and Nutrition Expertise
• Expanding Phenotypes of Female Heterozygotes in X-Linked Neurogenetic Conditions
• It’s All About the Vitamins [B]aby!

By attending this series, healthcare professionals will enhance their ability to interpret and apply genetic and genomic data in clinical practice, navigate ethical considerations, and leverage funding opportunities to support patient-centered research and care. This initiative underscores ACMG’s commitment to advancing genetics and genomics education while fostering collaboration across its diverse committee network.

Target Audience

This activity is designed for clinical geneticists, genetic counselors, laboratory professionals, and other healthcare providers involved in the diagnosis and management of genetic conditions. The content is also relevant to researchers and healthcare professionals seeking to stay up to date on emerging advancements and best practices in genetic conditions.

Learning Objectives

At the conclusion of this series, participants should be able to:

• Apply the latest advancements in clinical genetics and genomics to improve patient care, including innovations in gene therapy, diagnostic transcriptome RNA sequencing, and variant classification.
• Evaluate funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI) and identify strategies for supporting historically underserved patient populations through research initiatives.
• Interpret complex genetic findings and assess their clinical utility, limitations, and implications for patient management.
• Analyze ethical principles and challenges in genetic and genomic medicine, ensuring responsible and equitable application of genetic testing and counseling.
• Engage with ACMG committees to gain insights into emerging research, best practices, and collaborative efforts that shape the future of medical genetics and genomics.

Planners

Henry J. Mroczkowski, MD, PhD, FACMG (Chair)

University of TN Health Science Ctr

Jane Radford, MHA, CHCP

Director of Education - ACMG

Presenters and Moderators

	Anna Hurst, MD, MS, FACMG University of Alabama at Birmingham
	Margaret Adam, MD, MS, FAAP, FACMG Seattle Children's Hospital

Vanina Taliercio, MD University of Utah

Brittany Simpson, MD, FACMG St. Jude Children's Research Hospital

Fabiola Quintero-Rivera, MD, DABMGG, FACMG School of Medicine, University of California Irvine (UCI)

	Gloria Sheynkman, PhD University of Virginia
	Peter  J. Castaldi, MD, MSc Harvard Medical School

Paola Giusti-Rodriguez, PhD University of Florida

	Mina Ryten, MD, PhD University College London
	Colette Felton, PhD University Of California Santa Cruz
	Sydney Strickland, PhD, DABCC, FADLM Board member of the Pediatric Maternal Fetal Medicine Division of ADLM
	Nancy Leslie, MD Cincinnati Children’s Hospital
	Anna Scott, PhD, FACMG Seattle Children’s Hospital
	Heather E. Williams, PhD, MBA, MS, FACMG Co-Founder & Principal Consultant Medical Director GeneBetween
	Karen A. Robinson, MPA Senior Advisor, Equity Research and Innovation Center Yale School of Medicine
	Chris Kelly BGR Group
	Senator Daniel Zilkinov Montana State Legislature
	Julie Neidich, MD, FACMG Professor of Pathology and Immunology, Division of Genomics and Molecular Pathology, and of Pediatrics, Division of Genetics and Genomics Washington University in St. Louis (WashU Medicine)

	Shideh Mofidi, MS, RD Maria Fareri Children’s Hospital at Westchester Medical Center
	Leslie Martell, MS, RD, LDN Boston Children’s Hospital

	Kuntal Sen, MD, FACMG Children's National Hospital
	Mari Mori, MD, FACMG The Ohio State University

	Andrea Gropman, MD, FACMG St. Jude’s Children’s Research Hospital
	Stephen Chrzanowski MD, PhD University of Massachusetts Chan Medical School
	Nishitha Pillai, MBBS, FACMG University of Minnesota
	Jirair Bedoyan, MD, FACMG UPMC

Debra Regier, MD, PhD, FACMG Rare Disease Institute

	Kristina Cusmano-Ozog, MD, FACMG Stanford University School of Medicine
	Jennifer Harmon, MD, PhD Wake Forest University School of Medicine
	Curtis Coughlin, PhD, MS, MBE University of Colorado Anschutz Medical Campus
	Anna Scott, PhD, FACMG University of Washington
	Matthew Rasberry RD, CNSC University of Wisconsin Madison

CME AMA PRA Category 1^TM 

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 8.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

Claiming your Educational Credits

This activity consists of: View content, take a post-test, the test may be taken as often as necessary to achieve a passing score of 80% or better is required to receive credit.  If you do not achieve a passing score, the program will identify which questions you answered incorrectly so that you can review the module and try again. Complete the evaluation form.

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

Technical Support:
You can reach us by email at education@acmg.net or call 301-718-9603.
Support Center Hours: Monday – Friday, 9:00 AM – 5:00 PM Eastern Time.

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy

All of the relevant financial relationships listed for these individuals have been mitigated.